6-53269136-C-CCG
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_021814.5(ELOVL5):c.889_890dupCG(p.Lys298fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000496 in 1,613,550 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )
Consequence
ELOVL5
NM_021814.5 frameshift
NM_021814.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.25
Genes affected
ELOVL5 (HGNC:21308): (ELOVL fatty acid elongase 5) This gene belongs to the ELO family. It is highly expressed in the adrenal gland and testis, and encodes a multi-pass membrane protein that is localized in the endoplasmic reticulum. This protein is involved in the elongation of long-chain polyunsaturated fatty acids. Mutations in this gene have been associated with spinocerebellar ataxia-38 (SCA38). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELOVL5 | NM_021814.5 | c.889_890dupCG | p.Lys298fs | frameshift_variant | 8/8 | ENST00000304434.11 | NP_068586.1 | |
ELOVL5 | NM_001242828.2 | c.970_971dupCG | p.Lys325fs | frameshift_variant | 9/9 | NP_001229757.1 | ||
ELOVL5 | NM_001301856.2 | c.889_890dupCG | p.Lys298fs | frameshift_variant | 8/8 | NP_001288785.1 | ||
ELOVL5 | NM_001242830.2 | c.764_765dupCG | p.Glu256fs | frameshift_variant | 7/7 | NP_001229759.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELOVL5 | ENST00000304434.11 | c.889_890dupCG | p.Lys298fs | frameshift_variant | 8/8 | 1 | NM_021814.5 | ENSP00000306640.6 | ||
ELOVL5 | ENST00000542638.5 | c.764_765dupCG | p.Glu256fs | frameshift_variant | 7/7 | 1 | ENSP00000440728.2 | |||
ELOVL5 | ENST00000370918.8 | c.970_971dupCG | p.Lys325fs | frameshift_variant | 9/9 | 2 | ENSP00000359956.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250796Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135594
GnomAD3 exomes
AF:
AC:
3
AN:
250796
Hom.:
AF XY:
AC XY:
2
AN XY:
135594
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461246Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726930
GnomAD4 exome
AF:
AC:
5
AN:
1461246
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
726930
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74480
GnomAD4 genome
AF:
AC:
3
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 08, 2022 | Variant summary: ELOVL5 c.889_890dupCG (p.Lys298GlyfsX22) causes a frameshift which results in an extension of the protein and replaces the last two amino acids with 21 other amino acids. The variant allele was found at a frequency of 1.2e-05 in 250796 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.889_890dupCG in individuals affected with Spinocerebellar Ataxia Type 38 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at